Inovio Pharmaceuticals INO
NASDAQ INO
$1.48 +0.02 (+1.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Inovio Pharmaceuticals (INO) Return on Assets [ROA] (2009 - 2026)

Updated

Inovio Pharmaceuticals (INO) posted Return on Assets [ROA] of -156.22% for Q2 2026, down 37.29 percentage points from -118.93% a year earlier and down 24.58 percentage points from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For FY2025, Inovio Pharmaceuticals' Return on Assets [ROA] came in at -90.03%, down 14.14 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -41.04 percentage points (FY2020 to FY2025).
  • In prior years, Inovio Pharmaceuticals' Return on Assets [ROA] was -75.88% in FY2024 (-23.86 pp), -52.02% in FY2023 (+14.25 pp), -66.27% in FY2022 (-7.63 pp) and -58.64% in FY2021 (-9.65 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q3 2011.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last ten quarters, with an average year-over-year change of -25.63 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2023, with a gain of 10.49 percentage points; the weakest was Q2 2022, with a drop of 55.18 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -131.63% (Q1 2026), -117.47% (Q4 2025) and -126.27% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Inovio Pharmaceuticals 143.02 Mn -38.21 Mn - -129.90%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -129.90%
Jun 30, 2026 -135.99%
Mar 31, 2026 -136.89%
Dec 31, 2025 -118.23%
Sep 30, 2025 -157.08%
Jun 30, 2025 -112.87%
Mar 31, 2025 -96.25%
Dec 31, 2024 -97.39%
Sep 30, 2024 -93.73%
Jun 30, 2024 -92.53%
Mar 31, 2024 -83.27%
Dec 31, 2023 -74.23%
Sep 30, 2023 -77.24%
Jun 30, 2023 -67.42%
Mar 31, 2023 -78.49%
Dec 31, 2022 -75.58%
Sep 30, 2022 -78.06%
Jun 30, 2022 -78.39%
Mar 31, 2022 -69.75%
Dec 31, 2021 -58.87%
API Access

Inovio Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INO&period=max&api_key=YOUR_API_KEY